{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:55:26Z","timestamp":1771667726258,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>It has been reported that recombinant bovine basic fibroblast growth factor (rbFGF) may possess possible biological functions in promoting the process of wound healing. Consequently, our study aimed to investigate the hemostatic effect of topically applied rbFGF in patients who underwent a loop electrosurgical excision procedure (LEEP).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this retrospective analysis, we meticulously examined clinicopathologic data from a cohort of 90 patients who underwent LEEP at our institution between 2020 and 2021. Subsequently, we conducted inquiries with the patients to ascertain the degree of vaginal bleeding experienced during the postoperative periods of 3 and 6 weeks, comparing it to their preoperative menstrual flow. The magnitude of the menstrual volume alteration was then quantified using a menstrual volume multiplier(MVM). The primary endpoints of our investigation were to assess the hemostatic effect of rbFGF by means of evaluating the MVM. Additionally, the secondary endpoints encompassed the assessment of treatment-related side effects of such as infection and dysmenorrhea.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our findings demonstrated a significant reduction in hemorrhage following cervical LEEP. Specifically, in the per-protocol analysis, the study group exhibited a statistically significantly decrease in MVM after 3 weeks (0 [0\u20130] vs. 1 [0\u20131], respectively; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and after 6 weeks (1 [1] vs. 2 [1\u20133], respectively; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) of the procedure. No notable disparities were observed in the remaining outcomes between the two groups. Moreover, a logistic regression analysis was employed to explore the relationship between significant bleeding and rbFGF treatment (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, OR = -2.47, 95% CI -4.07 ~-1.21), while controlling for confounding factors such as age, BMI, and surgical specimen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In conclusion, our study findings highlight that the application of recombinant bovine basic fibroblast growth factorcan effectively mitigate hemorrhage subsequent to cervical loop electrosurgical excision procedure.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-023-02474-1","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T13:02:17Z","timestamp":1689944537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of recombinant bovine basic fibroblast growth factor to reduce hemorrhage after cervical loop electrosurgical excision procedure"],"prefix":"10.1186","volume":"23","author":[{"given":"Chongrong","family":"Weng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panxia","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghui","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huilong","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"2474_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijgo.2015.07.038","volume":"132","author":"N Santesso","year":"2016","unstructured":"Santesso N, Mustafa RA, Sch\u00fcnemann HJ, Arbyn M, Blumenthal PD, Cain J, et al. World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2\u20133 and screen-and-treat strategies to prevent cervical cancer. Int J Gynecol Obstet. 2016;132:252\u20138.","journal-title":"Int J Gynecol Obstet"},{"key":"2474_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/j.1471-0528.1989.tb03380.x","volume":"96","author":"W Prendiville","year":"1989","unstructured":"Prendiville W, Cullimore J, Norman S. Large loop excision of the transformation zone (LLETZ). A new method of management for women with cervical intraepithelial neoplasia. BJOG Int J Obstet Gynaecol. 1989;96:1054\u201360.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"2474_CR3","first-page":"173","volume":"79","author":"TC Wright","year":"1992","unstructured":"Wright TC, Gagnon S, Richart RM, Ferenczy A. Treatment of cervical intraepithelial neoplasia using the loop electrosurgical excision procedure. Obstet Gynecol. 1992;79:173\u20138.","journal-title":"Obstet Gynecol"},{"key":"2474_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ygyno.2020.09.053","volume":"159","author":"PA Cohen","year":"2020","unstructured":"Cohen PA, Leung Y, Anderson L, Van Der Griend R, Chivers P, Bilic S, et al. Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): a phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsy. Gynecol Oncol. 2020;159:623\u20139.","journal-title":"Gynecol Oncol"},{"key":"2474_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ijgo.2015.07.026","volume":"132","author":"N Santesso","year":"2016","unstructured":"Santesso N, Mustafa RA, Wiercioch W, Kehar R, Gandhi S, Chen Y, et al. Systematic reviews and meta-analyses of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia. Int J Gynecol Obstet. 2016;132:266\u201371.","journal-title":"Int J Gynecol Obstet"},{"key":"2474_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.11606\/s1518-8787.2020054001750","volume":"54","author":"Y Hurtado-Roca","year":"2020","unstructured":"Hurtado-Roca Y, Becerra-Chauca N, Malca M. Efficacy and safety of cryotherapy, cold cone or thermocoagulation compared to LEEP as a therapy for cervical intraepithelial neoplasia: systematic review. Rev Sa\u00fade P\u00fablica. 2020;54:27.","journal-title":"Rev Sa\u00fade P\u00fablica"},{"key":"2474_CR7","first-page":"84","volume":"18","author":"PG Signorile","year":"1997","unstructured":"Signorile PG, Anselmi Angeli R. Diagnostic and therapeutic technique of cervical conization with \u201ccold knife\u201d using fibrin glue. Preliminary outcomes. Eur J Gynaecol Oncol. 1997;18:84\u20136.","journal-title":"Eur J Gynaecol Oncol"},{"key":"2474_CR8","first-page":"CD001421","volume-title":"Cochrane database of systematic reviews","author":"PP Martin-Hirsch","year":"1999","unstructured":"Martin-Hirsch PP, Kitchener HC. Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasia. In: The Cochrane Collaboration, editor. Cochrane database of systematic reviews. Chichester, UK: John Wiley & Sons, Ltd; 1999. CD001421."},{"key":"2474_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000333266","volume":"74","author":"K Kim","year":"2012","unstructured":"Kim K, Park S-I, Kim B-J, Kim M-H, Choi S-C, Ryu S-Y, et al. Efficacy of Fibrin Sealant in reducing hemorrhage after a Loop Electrosurgical Excision Procedure. Gynecol Obstet Invest. 2012;74:1\u20135.","journal-title":"Gynecol Obstet Invest"},{"key":"2474_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000369391","volume":"80","author":"JH Kim","year":"2015","unstructured":"Kim JH, Park TC, Park GA, Song JY, Kim YH, Lee HJ, et al. A pilot study to investigate the efficacy of Fibrin Sealant (Tisseel\u00ae) in the Loop Electrosurgical Excision Procedure. Gynecol Obstet Invest. 2015;80:21\u20135.","journal-title":"Gynecol Obstet Invest"},{"key":"2474_CR11","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.1038\/s41598-020-62965-1","volume":"10","author":"GO Chong","year":"2020","unstructured":"Chong GO, Lee YH, Jeon SY, Yang H-Y, An S-H. Efficacy of a chitosan tampon in the loop electrosurgical excision procedure: a prospective randomized controlled study. Sci Rep. 2020;10:6017.","journal-title":"Sci Rep"},{"key":"2474_CR12","doi-asserted-by":"publisher","first-page":"tkaa035","DOI":"10.1093\/burnst\/tkaa035","volume":"8","author":"C Han","year":"2020","unstructured":"Han C, Cheng B, Wu P, writing group of growth factor guideline on behalf of Chinese Burn Association. Clinical guideline on topical growth factors for skin wounds. Burns Trauma. 2020;8:tkaa035.","journal-title":"Burns Trauma"},{"key":"2474_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.12809\/hkmj208743","volume":"27","author":"JK Ko","year":"2021","unstructured":"Ko JK, Lao TT, Cheung VY. Pictorial blood loss Assessment Chart for evaluating heavy menstrual bleeding in asian women. Hong Kong Med J. 2021;27:399\u2013404.","journal-title":"Hong Kong Med J"},{"key":"2474_CR14","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jmig.2014.01.015","volume":"21","author":"K Hald","year":"2014","unstructured":"Hald K, Lieng M. Assessment of periodic blood loss: interindividual and intraindividual variations of Pictorial Blood loss Assessment Chart Registrations. J Minim Invasive Gynecol. 2014;21:662\u20138.","journal-title":"J Minim Invasive Gynecol"},{"key":"2474_CR15","first-page":"21","volume":"12","author":"SD Quinn","year":"2016","unstructured":"Quinn SD, Higham J. Outcome measures for heavy menstrual bleeding. Womens Health. 2016;12:21\u20136.","journal-title":"Womens Health"},{"key":"2474_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1472-6874-12-24","volume":"12","author":"U Schumacher","year":"2012","unstructured":"Schumacher U, Schumacher J, Mellinger U, Gerlinger C, Wienke A, Endrikat J. Estimation of menstrual blood loss volume based on menstrual diary and laboratory data. BMC Womens Health. 2012;12:24.","journal-title":"BMC Womens Health"},{"key":"2474_CR17","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/S0140-6736(98)01260-4","volume":"352","author":"X Fu","year":"1998","unstructured":"Fu X, Shen Z, Chen Y, Xie J, Guo Z, Zhang M, et al. Randomised placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns. The Lancet. 1998;352:1661\u20134.","journal-title":"The Lancet"},{"key":"2474_CR18","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.3390\/ijms19071875","volume":"19","author":"Q Hui","year":"2018","unstructured":"Hui Q, Jin Z, Li X, Liu C, Wang X. FGF family: from Drug Development to Clinical Application. Int J Mol Sci. 2018;19:1875.","journal-title":"Int J Mol Sci"},{"key":"2474_CR19","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.3390\/cells10113242","volume":"10","author":"M Farooq","year":"2021","unstructured":"Farooq M, Khan AW, Kim MS, Choi S. The role of fibroblast growth factor (FGF) signaling in tissue repair and regeneration. Cells. 2021;10:3242.","journal-title":"Cells"},{"key":"2474_CR20","doi-asserted-by":"publisher","first-page":"tkac005","DOI":"10.1093\/burnst\/tkac005","volume":"10","author":"K Chen","year":"2022","unstructured":"Chen K, Rao Z, Dong S, Chen Y, Wang X, Luo Y, et al. Roles of the fibroblast growth factor signal transduction system in tissue injury repair. Burns Trauma. 2022;10:tkac005.","journal-title":"Burns Trauma"},{"key":"2474_CR21","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.abh3602","volume":"374","author":"Z \u00c1lvarez","year":"2021","unstructured":"\u00c1lvarez Z, Kolberg-Edelbrock AN, Sasselli IR, Ortega JA, Qiu R, Syrgiannis Z, et al. Bioactive scaffolds with enhanced supramolecular motion promote recovery from spinal cord injury. Science. 2021;374:848\u201356.","journal-title":"Science"},{"key":"2474_CR22","doi-asserted-by":"publisher","first-page":"100546","DOI":"10.1016\/j.mtbio.2023.100546","volume":"18","author":"F Wu","year":"2023","unstructured":"Wu F, Wang P, Wei X, Yang Y, Al Mamun A, Zhang X, et al. Barrier-penetrating liposome targeted delivery of basic fibroblast growth factor for spinal cord injury repair. Mater Today Bio. 2023;18:100546.","journal-title":"Mater Today Bio"},{"key":"2474_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature22322","volume":"545","author":"P Yu","year":"2017","unstructured":"Yu P, Wilhelm K, Dubrac A, Tung JK, Alves TC, Fang JS, et al. FGF-dependent metabolic control of vascular development. Nature. 2017;545:224\u20138.","journal-title":"Nature"},{"key":"2474_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.23736\/S2724-606X.20.04678-X","volume":"73","author":"M Monti","year":"2021","unstructured":"Monti M, D\u2019Aniello D, Scopelliti A, Tibaldi V, Santangelo G, Colagiovanni V, et al. Relationship between cervical excisional treatment for cervical intraepithelial neoplasia and obstetrical outcome. Minerva Obstet Gynecol. 2021;73:233\u201346.","journal-title":"Minerva Obstet Gynecol"},{"key":"2474_CR25","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3390\/vaccines11030698","volume":"11","author":"A Giannini","year":"2023","unstructured":"Giannini A, Di Donato V, Sopracordevole F, Ciavattini A, Ghelardi A, Vizza E, et al. Outcomes of High-Grade cervical dysplasia with positive margins and HPV persistence after cervical conization. Vaccines. 2023;11:698.","journal-title":"Vaccines"},{"key":"2474_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ygyno.2021.01.020","volume":"161","author":"G Bogani","year":"2021","unstructured":"Bogani G, Sopracordevole F, Di Donato V, Ciavattini A, Ghelardi A, Lopez S, et al. High-risk HPV-positive and -negative high-grade cervical dysplasia: analysis of 5-year outcomes. Gynecol Oncol. 2021;161:173\u20138.","journal-title":"Gynecol Oncol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02474-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02474-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02474-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T13:03:15Z","timestamp":1689944595000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02474-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2474"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02474-1","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"8 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declare no potential conflicts of interest for this article\u2019s research, authorship, and\/or publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of The Fifth Affiliated Hospital, Sun Yat-sen University and we obtained informed consent exemptions approved by the Ethics Committee of The Fifth Affiliated Hospital, Sun Yat\u2010sen University. The principles of the Declaration of Helsinki were followed. All methods were performed in accordance with the relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"385"}}